What influence the patients risk for chemotherapy


Case scenario:

Mr Wilson is a 57-year-old man who presents to his primary care provider for throat pain and difficulty swallowing. He is diagnosed with advanced stage oropharyngeal cancer and presents to the outpatient cancer center for high-dose cisplatin and concurrent external beam radiation. Students must assess the antiemetic regimens for breakthrough and delayed nausea and vomiting and make any changes necessary based on efficacy, side effects, and cost.

Answer questions based on the scenario: 

Q1. What subjective and objective information may influence the patient's risk for chemotherapy-induced nausea and vomiting?

Q2. Create a list of this patient's drug therapy problems and prioritize them. Include assessment of medication appropriateness, effectiveness, safety, and patient adherence.

Q3. What are the goals of therapy in this case?

Q4. What nondrug therapies may be useful to prevent nausea and vomiting?

Q5. What feasible pharmacotherapeutic alternatives are available for the prophylaxis of acute and delayed nausea and vomiting and for the treatment of breakthrough nausea and vomiting?

Q6. Create an individualized, patient-centered, team-based care plan to optimize medication therapy for this patient's chemotherapy-induced nausea and vomiting and other drug-related problems. Include specific drugs, dosage forms, schedules, and durations of therapy.

Q7. What information should be provided to the patient to enhance compliance, ensure successful therapy, and minimize adverse effects?

Q8. Describe how care should be coordinated with other healthcare providers.

Request for Solution File

Ask an Expert for Answer!!
Biology: What influence the patients risk for chemotherapy
Reference No:- TGS03378971

Expected delivery within 24 Hours